Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address Address Line 3 Entity Address City Or Town Entity Address Region Entity Address Country Entity Address Postal Zip Code City Area Code Local Phone Number Entity Interactive Data Current CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Statement Class Of Stock Axis Common Class A [Member] Common Class B [Member] ASSETS Current assets Cash Receivables Prepaid expenses Inventory Due from related parties Total Current Assets [Assets, Current] Property and equipment, net Intangible assets, net Operating lease right of use asset Lease security deposit Total Assets [Assets] LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable and accrued expenses (including accounts payable and accrued expenses of VIE without recourse to the Company of $1,349,598 and $1,008,758 as of September 30, 2026 and December 31, 2025, respectively) Advances from prospective customers (including advances from prospective customers of VIE without recourse to the Company of $467,713 and $440,344 as of September 30, 2026 and December 31, 2025, respectively) Due to related parties (including due to related parties of VIE without recourse to the Company of $1,527,807 and $1,061,372 as of September 30, 2026 and December 31, 2025, respectively) Operating lease liabilities - current (including operating lease liabilities - current of VIE without recourse to the Company of 0 and $78,783 as of September 30, 2026 and December 31, 2025, respectively) Total Current Liabilities [Liabilities, Current] Non-current liabilities Operating lease liabilities - non-current (including operating lease liabilities - non-current of VIE without recourse to the Company of 0 at September 30, 2026 and December 31, 2025) Total Liabilities [Liabilities] Commitments and contingencies Shareholders' Deficit: Preferred stock, par value $0.01 per share, 5,000,000 shares authorized, none issued Common stock, value Additional Paid in Capital Accumulated deficit Accumulated other comprehensive income (loss) Total deficit attributable to common shareholders [Equity, Attributable to Parent] Non-controlling interests Total Deficit [Equity, Including Portion Attributable to Noncontrolling Interest] Total Liabilities and Shareholders' Equity [Liabilities and Equity] Accounts payable and accrued expenses of variable interest entity Advances from prospective customers of variable interest entity Due to related parties of variable interest entity Variable interest entity operating lease liabilities, current Variable interest entity operating lease liabilities, non current Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) Revenue Sales of products and services Cost of goods and services sold Gross Profit [Gross Profit] Operating expenses: Employee compensation Occupancy Depreciation and amortization of property and equipment Amortization of intangible assets Other operating expenses Total Operating Expenses [Operating Expenses] Income (loss) from operations [Operating Income (Loss)] Other Income (Expenses) Other income (expenses), net Total Other Income (Expenses) [Nonoperating Income (Expense)] Loss before Provision for Income Tax [Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest] Provision for Income Tax Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Net loss attributable to non-controlling interest Net loss attributable to common stockholders [Net Income (Loss) Attributable to Parent] Net loss per share basic and diluted Weighted average common shares outstanding basic and diluted Comprehensive income (loss) Net loss to the Company Net loss to non-controlling interests Foreign currency translation adjustment to the Company Foreign currency translation adjustment to non-controlling interests Total comprehensive income (loss) [Comprehensive Income (Loss), Net of Tax, Attributable to Parent] CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (Unaudited) Equity Components [Axis] Common Stock Class A Common Stock Class B Total Company's deficit Additional paid in capital Accumulated Deficit Accumulated other comprehensive Income (loss) Noncontrolling Interest Balance, shares [Shares, Issued] Balance, amount Issuance of ordinary shares, shares Issuance of ordinary shares, amount Net loss Foreign currency translation adjustment Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Bad debt of prepaid expenses Changes in operating assets and liabilities: Receivables [Increase (Decrease) in Receivables] Prepaid expense [Increase (Decrease) in Prepaid Expense] Lease security deposit [Increase (Decrease) in Security Deposits] Accounts payable and accrued expenses Advances from prospective customers Net cash used in operating activities [Cash Provided by (Used in) Operating Activity, Including Discontinued Operation] Cash flows from investing activities: Proceeds for sale of Equipment Net cash provided in investing activities [Cash Provided by (Used in) Investing Activity, Including Discontinued Operation] Cash flows from financing activities: Advances from related parties (net) Net cash provided by financing activities [Cash Provided by (Used in) Financing Activity, Including Discontinued Operation] Effect of exchange rate changes Net increase (decrease) in cash [Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation] Cash at beginning of period Cash at end of period Supplemental Cash Flow Information: Income taxes paid Interest paid Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangements Adopted [Flag] Rule 10b5-1 Arrangements Terminated [Flag] Non Rule 10b5-1 Arrangements Adopted [Flag] Non Rule 10b5-1 Arrangements Terminated [Flag] Material Terms of Trading Arrangements [Text Block] ORGANIZATION ORGANIZATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] GOING CONCERN GOING CONCERN Substantial Doubt about Going Concern [Text Block] INVENTORY INVENTORY Inventory Disclosure [Text Block] DUE FROM RELATED PARTIES DUE FROM RELATED PARTIES [DUE FROM RELATED PARTIES] PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] INTANGIBLE ASSETS INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] OPERATING LEASE RIGHT OF USE ASSETS AND OPERATING LEASE LIABILITIES OPERATING LEASE RIGHT OF USE ASSETS AND OPERATING LEASE LIABILITIES Lessee, Operating Leases [Text Block] ADVANCES FROM PROSPECTIVE CUSTOMERS ADVANCES FROM PROSPECTIVE CUSTOMERS [ADVANCES FROM PROSPECTIVE CUSTOMERS] DUE TO RELATED PARTIES DUE TO RELATED PARTIES [DUE TO RELATED PARTIES] SHAREHOLDERS EQUITY SHAREHOLDERS' EQUITY RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] INCOME TAX INCOME TAX Income Tax Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] MAJOR CUSTOMERS MAJOR CUSTOMERS [MAJOR CUSTOMERS] CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS [CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS] Basis of Presentation Interim Financial Information Principles of Consolidation Foreign Currency Translation Use of Estimates Cash and Cash Equivalents Inventories Property and Equipment Intangible Assets Impairment of Long-Lived Assets Fair Value of Financial Instruments Leases Revenue Recognition Allowance for Doubtful Accounts Advertising Costs Income Taxes Net Income (Loss) per Share Comprehensive Income (Loss) Schedule of information of company and its subsidiaries Schedule of consolidated assets and liabilities of Yubo Beijing (VIE) and its subsidiaries Schedule of remaining term of lease of property and equipment Schedule of amortization period of intangible assets Schedule of inventory Schedule of due from related parties Schedule of property and equipment Schedule of intangible assets Schedule of amortization of intangible assets expense Schedule of advances from prospective customers and distributors Schedule of due to related parties Summary of class a common stock issued for acquisition of platinum Summary of shares issued by platinum to other six entities Schedule of composition of income tax expense Schedule of deferred tax assets Schedule of reconciliation of income tax provision at PRC tax rate Schedule of condensed consolidating balance sheet Schedule of condensed consolidating statement of operations Business Acquisition Axis Related Party Transactions By Related Party Axis Plan Name [Axis] Related Party Transaction [Axis] Yubo Jinghzi [Member] EpiAis Biomedical Engineering (Shenzhen) Co., Ltd (Yubo Phoenix) [Member] Platinum and Yubo Beijing [Member] Common Class A [Member] Exchange Agreement [Member] Common Stock Class A [Member] Lina Liu [Member] Liu Lina [Member] Parent ownership percentage Noncontrolling interest ownership percentage Business acquisition, percentage of voting interests acquired Common stock, shares issued Common stock, shares outstanding Ownership percentage Cancellation of shares held by related party Schedule Of Equity Method Investment Equity Method Investee Name Axis Income Tax Authority, Name [Axis] Consolidated Entities [Axis] Platinum International Biotech Co. LTD [Member] Platinum HK [Member] Yubo International Biotech (Chengdu) Limited [Member] Yubo International Biotech (Beijing) Limited [Member] Yubo Jingzhi [Member] Yubo Global [Member] Phoenix Club Bio-Medical Technology [Member] EpiAis Biomedical Engineering Co., Ltd. [Member] Name of company Ownership percentage Date of incorporation Subscribed capital Voting interest equity Yubo Beijing (VIE) [Member] Cash [Cash Equivalents, at Carrying Value] Receivables (net) Prepaid Expenses Inventory Due from related parties Property and equipment (net) Intangible assets (net) Operating Lease, Right-of-Use Asset Lease security deposit Receivables from other consolidated entities Total assets Accounts payable and accrued expenses Advances from prospective customers/distributors Due to related parties Operating lease liabilities Payables to other consolidated entities Total liabilities Shareholders' equity Long-Lived Tangible Asset [Axis] Air conditioning equipment [Member] Office Equipment [Member] Leasehold improvements, remaining term of lease Finite-Lived Intangible Assets by Major Class [Axis] Distribution software [Member] Patents [Member] Intangible assets, amortization period Assets and liabilities currency translation Currency translation description Cash Working capital Public Utilities Inventory Axis Nebulizers and components [Member] Oral liquid and health products [Member] Other [Member] Beauty care products [Member] Total Inventory Beijing Zhenhuikang Biotechnology Co., LTD [Member] Due from related parties Leasehold improvements X-Ray equipment Office equipment Total property and equipment Less accumulated depreciation and amortization [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Property and equipment, net Depreciation and amortization of property and equipment [Depreciation, Depletion and Amortization] Distribution software Experience centre software Patents acquired from related party Wechat application Total intangible assets Less: Accumulated amortization [Finite-Lived Intangible Assets, Accumulated Amortization] Intangible assets, net Year ending December 31, 2026 Thereafter Amortization of intangible assets Lease Contractual Term [Axis] Operating Lease [Member] Occupancy expense Lease term expiration Lease agreement, description Major Customers Axis PRC Entities One [Member] PRC Entities Two [Member] PRC Entities Three [Member] PRC Entities Four [Member] PRC Entities Five [Member] PRC Entities Six [Member] PRC Entities Seven [Member] PRC Entities Eight [Member] PRC Entities Nine [Member] Advancer, Total [Member] Advances from prospective customers [Customer Advances and Deposits] Title Of Individual Axis Mr. Yang Wang [Member] Mr. Jun Wang [Member] Ms. Huang Li [Member] Mr. Yanxin Wang [Member] Due to related parties Beneficial ownership or percentage held to related party Flydragon International Limited [Member] Chinaone Technology Limited [Member] Boao Biotech Limited [Member] Focus Draw Group Limited [Member] Focusone Technology Group Limited [Member] Dragoncloud Technology Limited [Member] Cheung Ho Shun [Member] Number of Exchange Shares Percentage of Exchange Shares Ordinary shares issued Common Class B [Member] FlyDragon [Member] Platinum and Yubo Beijing [Member] Common Class A [Member] [Common Class A [Member]] ChinaOne [Member] Preferred stock, par value Preferred shares authorized Subscribed capital paid Percentage of ownership interest Settlement liabilities amount Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Shares issued Number of shares issued during the period Purchase price per share Subscribed capital [Common Stock, Shares Subscribed but Unissued] Ordinary shares, par value Ordinary shares, authorized Ordinary shares, issued Ordinary shares, outstanding Sale of ordinary shares Sale of ordinary shares in cash Ordinary shares acquired Current income tax expense Deferred income tax expense [Deferred Income Tax Expense (Benefit)] Provision for income taxes Deferred tax assets, gross Valuation allowance [Deferred Tax Assets, Valuation Allowance] Deferred tax assets, net Loss before provision for income taxes Income tax benefit computed at an applicable tax rate of 25% Change in valuation allowance Provision for income taxes Statutory income tax rate Cash deposits Sales Parent Company [Member] Yubo International Biotech Limited Yubo Chengdu (WFOE) Yubo Beijing (VIE) and Subsidiaries Eliminations Platinum (Cayman Islands) and Limited Platinum HK Total Current Assets Investment in subsidiaries and variable interest entity (VIE) Intercompany receivables Other assets [Other assets] Total Assets Total Current Liabilities Intercompany payables Other liabilities Total Liabilities [Total Liabilities] Capital stock and additional paid in capital [Capital stock and additional paid in capital] Accumulated deficit Accumulated other comprehensive income (loss) Non-controlling interests Total Deficit [Total Deficit] Total Liabilities and Shareholders' Equity [Total Liabilities and Shareholders' Equity] Other assets Total Assets [Total Assets] Capital stock and additional paid in capital Yubo Global Yubo Beijing VIE And Subsidiaries Sales of products and services Cost of goods and services sold Gross Profit Total Operating Expenses Loss from operations Other income (expense) Equity in net loss of subsidiaries and variable interest entity (VIE) Net loss